StageZero Life Sciences Ltd.
SZLSF
$0.0021
-$0.025-92.25%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -12.53M | -12.53M |
| Total Depreciation and Amortization | -- | -- | -- | 283.10K | 283.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | 64.90K | 64.90K |
| Total Other Non-Cash Items | -- | -- | -- | 8.22M | 8.22M |
| Change in Net Operating Assets | -- | -- | -- | 3.14M | 3.14M |
| Cash from Operations | -- | -- | -- | -823.50K | -823.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 711.60K | 711.60K |
| Total Debt Repaid | -- | -- | -- | -548.00K | -548.00K |
| Issuance of Common Stock | -- | -- | -- | 551.50K | 551.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 112.10K | 112.10K |
| Cash from Financing | -- | -- | -- | 827.50K | 827.50K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -13.00K | -13.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -9.20K | -9.20K |
